Back to company

PHARMA-TECH A/S: Financial statements 2023

CVR: 32940897

PHARMA-TECH A/S (CVR 32940897) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 24,106,590 and a net result of DKK 6,453,098 compared with DKK 4,335,927 the year before. That is an increase of 24.7% compared with the year before. Equity amounted to DKK 24,220,453. The solvency ratio was 59.7%. The company had 23 employees in the financial year.

Gross Profit
24,106,590 kr.
Profit/Loss
6,453,098 kr.
Equity
24,220,453 kr.
Total Assets
40,568,330 kr.
Employees
23

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-24.1 mio.6.5 mio.24.2 mio.23
2022-19.3 mio.4.3 mio.19.8 mio.21
2021-18 mio.3.1 mio.17.4 mio.21
2020-29 mio.11.9 mio.22.3 mio.21
2019-15.3 mio.3.5 mio.10.5 mio.20

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

PHARMA-TECH A/S: The 2022 annual report is outMar 22, 2023

PHARMA-TECH A/S has published its annual report for 2022. Gross profit came to DKK 19,333,355, and the net result was DKK 4,335,927.

About PHARMA-TECH A/S

PHARMA-TECH A/S is a Danish company of the type Aktieselskab based in Randers SV, founded in 2010. The company is registered under the industry Fremstilling af plastemballage. The management consists of Morten Hart Johansen. The company is owned by JoWin Holding ApS. The company has 24 employees. In 2025, the company reported a gross profit of DKK 32,243,339 and a net result of DKK 5,636,893 compared with DKK 6,599,234 the year before. Equity amounted to DKK 24,456,581.